Astera Labs Stock Fell 10% After Its Nasdaq-100 Debut: Here’s What Has to Hold Up the Stock Now

Key Stats for Astera Labs Stock

• Current Price: $397.02 
• Target Price (Mid): ~$850
• Street Target: ~$255
• Potential Total Return: ~115%
• Annualized IRR: ~18% / year
• Max Drawdown: (60.19%) on March 30, 2026

Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free) >>>

What Happened?

Astera Labs (ALAB) had the kind of bad day its own bulls saw coming. The connectivity chipmaker joined the Nasdaq-100 before the open on June 22, 2026, touching an all-time high near $441 on the way in. Then the forced buying stopped, and on June 23, the stock fell 9.70% to close at $397.02.

For weeks, the easy explanation for the climb was mechanical. Every fund tracking the Nasdaq-100 must own the stock in proportion, and the Invesco QQQ alone runs over $300 billion, creating price-insensitive buying into the effective date. Bulls said the business was real underneath the flows. Bears said the flows were the rally. The drop did not settle that. It removed the easiest reason to own the stock and handed the floor back to fundamentals.

So the question is now narrow: with the index bid gone, what holds Astera Labs up? The answer lies in the company’s investor relations materials, its new CFO’s framing, and the TIKR model, which prices the stock on the business rather than the buy program.

Why the index pop reversed

Index inclusion is a known trade, and known trades unwind. Astera entered alongside CoreWeave, Nebius Group, Rocket Lab, and Teradyne, replacing names like Charter Communications and Zscaler. All five new entrants sold off on debut day, so Astera was not singled out. It ran with the group, then mean-reverted once the passive demand cleared.

The drop also has to be measured against the run. ALAB had climbed roughly 200% over the prior three months, so a 9.70% pullback barely dents the chart. The stock still sits near the top of its 52-week range of $84.78 to $440.99. What changed is the source of demand: the mechanical buyer is finished, and from here the stock trades on whether the second-half story arrives on schedule.

See historical and forward estimates for Astera Labs stock (It’s free!) >>>

The business underneath the flows

The fundamentals are not the problem. Astera reported record revenue of $308.4 million last quarter, up 93% year over year, beating consensus by 5.49%. Gross margin held at 76%, and TIKR shows the company carrying a net cash position of roughly $1.1 billion.

The growth engine is the Scorpio switch family, Astera’s smart fabric switches that route high-speed traffic between processors inside AI server racks. Scorpio made up about 15% of revenue last year, and management expects it to become the largest product line by the end of 2026. The flagship 320-lane Scorpio X, built for scale-up AI clusters, enters volume production in the second half of the year.

That timing lines up with when index support disappears. At the Evercore Global TMT Conference on June 3, new CFO Desmond Lynch, about 90 days into the role, sized the prize directly: “We’re talking about $4 billion on the scale-out applications as well as $10 billion on the scale-up, which is really a greenfield sort of opportunity for us.” The quote matters because Astera is entering the scale-up market nearly first, not fighting for share in it.

The content-per-chip engine

The most important number for Astera is not revenue. It is dollar content per accelerator, meaning how much of Astera’s hardware attaches to each AI chip. At IPO, that figure sat in the low hundreds of dollars. Today it is over $1,000, as the company bolted Taurus cable modules and Scorpio switches around its original Aries retimers, which clean and extend high-speed signals between processors.

SVP of Finance Nick Aberle framed the trajectory when an analyst asked whether $10,000 was next: “From what we can see today in the next several generations, we very confidently say that our content opportunity per accelerator will continue to grow at a very robust clip.” That is the structural tailwind under the revenue growth forecasts, and it does not depend on any index.

The skeptical case has never been about the business. It is about price. Even after the drop, ALAB trades at an NTM EV/EBITDA of around 99x and an NTM P/E of around 118x. On TIKR’s Competitors page, NVIDIA sits near 16x NTM EV/EBITDA, Broadcom near 19x, and Marvell near 49x, with the peer mean around 33x. Astera trades at roughly three times that average, a premium that holds only if growth stays extraordinary for years.

Insiders have noticed the same math. Over the past year, executives and directors sold roughly $155 million more stock than they bought, including about $57.9 million from CEO Jitendra Mohan’s trusts in April. Most ran through pre-arranged 10b5-1 plans adopted in December 2025, so it is not a timing signal, but it is the people closest to the business taking money off the table.

See how Astera Labs performs against its peers in TIKR (It’s free!) >>>

TIKR Advanced Model Analysis

• Current Price: $397.02
• Target Price (Mid): ~$850
• Potential Total Return: ~115%
• Annualized IRR: ~18% / year

See analysts’ growth forecasts and price targets for Astera Labs stock (It’s free!) >>>

Using the TIKR mid-case scenario, realized at 12/31/30, the model points to a target of around $850, a total return of around 115% over 4.5 years, and an annualized return of around 18%. The mid case is the honest one, because the stock already trades far above the Street mean target of around $255.

Two revenue drivers anchor it: the Scorpio ramp, led by the 320-lane Scorpio X entering volume production in the second half of 2026 against the $10 billion scale-up market Lynch described, and rising content per accelerator across the portfolio. The margin driver is Astera’s free cash flow profile, with a net income margin the model holds near 36%, supported by 76% gross margins.

The primary risk is a Scorpio X slip or a pause in hyperscaler AI capex, which would hit the earnings base and the premium multiple at once. 

The upside: scale-up, optical, and UALink add new content on top of a growing base, and the mid case proves conservative. 

The downside: growth decelerates and the multiple reverts toward peers, a long way down from 99x.

Conclusion

The index trade is over, and that is clarifying, not bearish. From here, Astera Labs trades on one thing: whether Scorpio X volume production shows up in the numbers. The first read comes on August 4, when the company reports Q2. Good looks like revenue at or above the guided $355 million to $365 million range with gross margin near the guided 73%. Bad looks like a production slip or margin sliding below the low 70s, which would tell investors the premium is no longer backed by execution. The bid that carried the stock to $441 is gone. August 4 is when the business has to take over.

See what stocks billionaire investors are buying so you can follow the smart money with TIKR.

Should You Invest in Astera Labs?

The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.

Pull up Astera Labs, and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.

You can build a free watchlist to track Astera Labs alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.

Analyze Astera Labs on TIKR Free →

Looking for New Opportunities?

• See what stocks billionaire investors are buying so you can follow the smart money.
• Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
• The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.

Disclaimer:

Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!